The Impact of COVID-19 on Syringe Services Programs in the United States
AIDS Behav
.
2020 Sep;24(9):2466-2468.
doi: 10.1007/s10461-020-02886-2.
Authors
Sara N Glick
1
,
Stephanie M Prohaska
2
,
Paul A LaKosky
2
,
Alexa M Juarez
3
,
Maria A Corcorran
3
,
Don C Des Jarlais
4
Affiliations
1
School of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA. snglick@uw.edu.
2
Dave Purchase Project, North American Syringe Exchange Network, Tacoma, WA, USA.
3
School of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
4
College of Global Public Health, New York University, New York, NY, USA.
PMID:
32333209
PMCID:
PMC7182093
DOI:
10.1007/s10461-020-02886-2
No abstract available
Publication types
Editorial
Grants and funding
T32 DK007742/DK/NIDDK NIH HHS/United States